News Headlines Article

Trump administration proposes big changes in how prescription drugs are priced
Washington Post

The Trump administration on Thursday proposed bringing transparency to one of the most secretive aspects of drug pricing by ending the widespread practice of rebates to middlemen — an effort to reduce what consumers pay for prescription medicine.

Under draft rules announced by Health and Human Services Secretary Alex Azar, drug manufacturers would be allowed to offer discounted prices directly to consumers but would no longer be able to give rebates to the middlemen, known as pharmacy benefit managers.